3-hydroxybenzeneacetic acid has been researched along with Cancer of Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurita, A; Li, K; Liu, X; Liu, Y; Motoyama, A; Munemasa, S; Murata, Y; Myojin, T; Nakamura, T; Nakamura, Y; Satoh, A; Seto, M | 1 |
1 other study(ies) available for 3-hydroxybenzeneacetic acid and Cancer of Liver
| Article | Year |
|---|---|
A Major Intestinal Catabolite of Quercetin Glycosides, 3-Hydroxyphenylacetic Acid, Protects the Hepatocytes from the Acetaldehyde-Induced Cytotoxicity through the Enhancement of the Total Aldehyde Dehydrogenase Activity.
Topics: Acetaldehyde; Aldehyde Dehydrogenase; Carcinoma, Hepatocellular; Cell Death; Cell Nucleus; Cytoprotection; Glycosides; Hep G2 Cells; Hepatocytes; Humans; Intestines; Isoenzymes; Liver Neoplasms; NF-E2-Related Factor 2; Phenylacetates; Protective Agents; Quercetin; Receptors, Aryl Hydrocarbon; RNA, Messenger | 2022 |